398 Efficacy and safety of ixekizumab for the treatment of plaque psoriasis: Results through 108 weeks randomised, phase III clinical trial (UNCOVER-3)

Details

Language :

English

ISSN :

0022202X and 15231747

Volume :

137

Issue :

10, Number 10 Supplement 2

Database :

Supplemental Index

Journal :

Journal of Investigative Dermatology

Publication Type :

Periodical

Accession number :

ejs43073575

Full Text :

https://doi.org/10.1016/j.jid.2017.07.593